Completed
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
NCT01665352
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Site 18 Chula Vista, California, United States
- Site 1 Los Angeles, California, United States
- Site 13 Denver, Colorado, United States
- Site 4 Coral Gables, Florida, United States